University of Washington self-efficacy scale: A new self-efficacy scale for people with disabilities

Dagmar Amtmann; Alyssa M. Bamer; Karon F. Cook; Robert L. Askew; Vanessa K. Noonan; Jo Ann Brockway

doi:10.1016/j.apmr.2012.05.001

University of Washington self-efficacy scale: A new self-efficacy scale for people with disabilities

Dagmar Amtmann^*, Alyssa M. Bamer, Karon F. Cook, Robert L. Askew, Vanessa K. Noonan, Jo Ann Brockway

^*Corresponding author for this work

Medical Social Sciences

Research output: Contribution to journal › Article › peer-review

102 Scopus citations

Abstract

Amtmann D, Bamer AM, Cook KF, Askew RL, Noonan VK, Brockway JA. University of Washington Self-Efficacy Scale: a new self-efficacy scale for people with disabilities. Objective: To develop a self-efficacy scale for people living with multiple sclerosis (MS) and spinal cord injury (SCI) that can be used across diagnostic conditions. Design: The scale was developed using modern psychometric methods including item response theory. Items were administered at 3 time-points of a longitudinal survey of individuals with MS and SCI. Setting: Survey participants with MS were recruited from the National MS Society, and participants with SCI were recruited from the Northwest Regional Spinal Cord Injury Model System and the Shepherd Center at the Virginia Crawford Research Institute in Atlanta, GA. Participants: Adults aged 18 years and older reporting a definitive diagnosis of MS (N=473) or SCI (N=253). Interventions: None. Main Outcome Measures: Evaluation of the new self-efficacy measure called the University of Washington Self-Efficacy Scale (UW-SES) included comparisons with the Chronic Disease Self-Efficacy Scale and other patient-reported outcome measures. Results: UW-SES has excellent psychometric properties including well-functioning response categories, no floor effects, and low ceiling effects. A long form (17 items) and a short form (6 items) are available. The correlation between the score on the newly developed scale and the Chronic Disease Self-Efficacy Scale was high (.83), providing support for convergent validity. Higher self-efficacy scores were statistically significantly associated with better mental health, better physical health, less fatigue, less stress, less pain interference, less pain, fewer sleep problems, and lower depressive symptoms. Conclusions: The UW-SES is a psychometrically sound instrument for measuring self-efficacy, validated in MS and SCI, and can be used across both conditions. Both the long form and the short form are available free of charge.

Original language	English (US)
Pages (from-to)	1757-1765
Number of pages	9
Journal	Archives of physical medicine and rehabilitation
Volume	93
Issue number	10
DOIs	https://doi.org/10.1016/j.apmr.2012.05.001
State	Published - Oct 2012

Funding

Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant nos. H133B031129 and H133B080025 ), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Health (grant no. 5U01AR052171 ). However, these contents do not necessarily represent the policy of the Department of Education, and one should not assume endorsement by the federal government.

Keywords

Multiple sclerosis
Patient outcome assessment
Rehabilitation
Self-efficacy
Spinal cord injuries

ASJC Scopus subject areas

Rehabilitation
Physical Therapy, Sports Therapy and Rehabilitation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.apmr.2012.05.001

Cite this

@article{d37d03be48f74731babf02f5c57c0714,

title = "University of Washington self-efficacy scale: A new self-efficacy scale for people with disabilities",

abstract = "Amtmann D, Bamer AM, Cook KF, Askew RL, Noonan VK, Brockway JA. University of Washington Self-Efficacy Scale: a new self-efficacy scale for people with disabilities. Objective: To develop a self-efficacy scale for people living with multiple sclerosis (MS) and spinal cord injury (SCI) that can be used across diagnostic conditions. Design: The scale was developed using modern psychometric methods including item response theory. Items were administered at 3 time-points of a longitudinal survey of individuals with MS and SCI. Setting: Survey participants with MS were recruited from the National MS Society, and participants with SCI were recruited from the Northwest Regional Spinal Cord Injury Model System and the Shepherd Center at the Virginia Crawford Research Institute in Atlanta, GA. Participants: Adults aged 18 years and older reporting a definitive diagnosis of MS (N=473) or SCI (N=253). Interventions: None. Main Outcome Measures: Evaluation of the new self-efficacy measure called the University of Washington Self-Efficacy Scale (UW-SES) included comparisons with the Chronic Disease Self-Efficacy Scale and other patient-reported outcome measures. Results: UW-SES has excellent psychometric properties including well-functioning response categories, no floor effects, and low ceiling effects. A long form (17 items) and a short form (6 items) are available. The correlation between the score on the newly developed scale and the Chronic Disease Self-Efficacy Scale was high (.83), providing support for convergent validity. Higher self-efficacy scores were statistically significantly associated with better mental health, better physical health, less fatigue, less stress, less pain interference, less pain, fewer sleep problems, and lower depressive symptoms. Conclusions: The UW-SES is a psychometrically sound instrument for measuring self-efficacy, validated in MS and SCI, and can be used across both conditions. Both the long form and the short form are available free of charge.",

keywords = "Multiple sclerosis, Patient outcome assessment, Rehabilitation, Self-efficacy, Spinal cord injuries",

author = "Dagmar Amtmann and Bamer, {Alyssa M.} and Cook, {Karon F.} and Askew, {Robert L.} and Noonan, {Vanessa K.} and Brockway, {Jo Ann}",

note = "Funding Information: Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant nos. H133B031129 and H133B080025 ), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Health (grant no. 5U01AR052171 ). However, these contents do not necessarily represent the policy of the Department of Education, and one should not assume endorsement by the federal government. ",

year = "2012",

month = oct,

doi = "10.1016/j.apmr.2012.05.001",

language = "English (US)",

volume = "93",

pages = "1757--1765",

journal = "Archives of physical medicine and rehabilitation",

issn = "0003-9993",

publisher = "W.B. Saunders Ltd",

number = "10",

}

TY - JOUR

T1 - University of Washington self-efficacy scale

T2 - A new self-efficacy scale for people with disabilities

AU - Amtmann, Dagmar

AU - Bamer, Alyssa M.

AU - Cook, Karon F.

AU - Askew, Robert L.

AU - Noonan, Vanessa K.

AU - Brockway, Jo Ann

N1 - Funding Information: Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant nos. H133B031129 and H133B080025 ), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Health (grant no. 5U01AR052171 ). However, these contents do not necessarily represent the policy of the Department of Education, and one should not assume endorsement by the federal government.

PY - 2012/10

Y1 - 2012/10

N2 - Amtmann D, Bamer AM, Cook KF, Askew RL, Noonan VK, Brockway JA. University of Washington Self-Efficacy Scale: a new self-efficacy scale for people with disabilities. Objective: To develop a self-efficacy scale for people living with multiple sclerosis (MS) and spinal cord injury (SCI) that can be used across diagnostic conditions. Design: The scale was developed using modern psychometric methods including item response theory. Items were administered at 3 time-points of a longitudinal survey of individuals with MS and SCI. Setting: Survey participants with MS were recruited from the National MS Society, and participants with SCI were recruited from the Northwest Regional Spinal Cord Injury Model System and the Shepherd Center at the Virginia Crawford Research Institute in Atlanta, GA. Participants: Adults aged 18 years and older reporting a definitive diagnosis of MS (N=473) or SCI (N=253). Interventions: None. Main Outcome Measures: Evaluation of the new self-efficacy measure called the University of Washington Self-Efficacy Scale (UW-SES) included comparisons with the Chronic Disease Self-Efficacy Scale and other patient-reported outcome measures. Results: UW-SES has excellent psychometric properties including well-functioning response categories, no floor effects, and low ceiling effects. A long form (17 items) and a short form (6 items) are available. The correlation between the score on the newly developed scale and the Chronic Disease Self-Efficacy Scale was high (.83), providing support for convergent validity. Higher self-efficacy scores were statistically significantly associated with better mental health, better physical health, less fatigue, less stress, less pain interference, less pain, fewer sleep problems, and lower depressive symptoms. Conclusions: The UW-SES is a psychometrically sound instrument for measuring self-efficacy, validated in MS and SCI, and can be used across both conditions. Both the long form and the short form are available free of charge.

AB - Amtmann D, Bamer AM, Cook KF, Askew RL, Noonan VK, Brockway JA. University of Washington Self-Efficacy Scale: a new self-efficacy scale for people with disabilities. Objective: To develop a self-efficacy scale for people living with multiple sclerosis (MS) and spinal cord injury (SCI) that can be used across diagnostic conditions. Design: The scale was developed using modern psychometric methods including item response theory. Items were administered at 3 time-points of a longitudinal survey of individuals with MS and SCI. Setting: Survey participants with MS were recruited from the National MS Society, and participants with SCI were recruited from the Northwest Regional Spinal Cord Injury Model System and the Shepherd Center at the Virginia Crawford Research Institute in Atlanta, GA. Participants: Adults aged 18 years and older reporting a definitive diagnosis of MS (N=473) or SCI (N=253). Interventions: None. Main Outcome Measures: Evaluation of the new self-efficacy measure called the University of Washington Self-Efficacy Scale (UW-SES) included comparisons with the Chronic Disease Self-Efficacy Scale and other patient-reported outcome measures. Results: UW-SES has excellent psychometric properties including well-functioning response categories, no floor effects, and low ceiling effects. A long form (17 items) and a short form (6 items) are available. The correlation between the score on the newly developed scale and the Chronic Disease Self-Efficacy Scale was high (.83), providing support for convergent validity. Higher self-efficacy scores were statistically significantly associated with better mental health, better physical health, less fatigue, less stress, less pain interference, less pain, fewer sleep problems, and lower depressive symptoms. Conclusions: The UW-SES is a psychometrically sound instrument for measuring self-efficacy, validated in MS and SCI, and can be used across both conditions. Both the long form and the short form are available free of charge.

KW - Multiple sclerosis

KW - Patient outcome assessment

KW - Rehabilitation

KW - Self-efficacy

KW - Spinal cord injuries

UR - http://www.scopus.com/inward/record.url?scp=84866355110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866355110&partnerID=8YFLogxK

U2 - 10.1016/j.apmr.2012.05.001

DO - 10.1016/j.apmr.2012.05.001

M3 - Article

C2 - 22575393

AN - SCOPUS:84866355110

SN - 0003-9993

VL - 93

SP - 1757

EP - 1765

JO - Archives of physical medicine and rehabilitation

JF - Archives of physical medicine and rehabilitation

IS - 10

ER -

University of Washington self-efficacy scale: A new self-efficacy scale for people with disabilities

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this